Second Biogen/Eisai Antibody Moves AHEAD, In Asymptomatic Alzheimer’s

Early Intervention Benefits?

 
• By Ian Haydock

More progress for partners’ amyloid-targeting antibody portfolio as they look to demonstrate benefit of early intervention in pre-symptomatic disease in new collaborative Phase III trial.

Elderly woman hands holding missing white jigsaw puzzle piece down into the place as a human head brain shape. Creative idea for memory loss, dementia, Alzheimer's disease and mental health concept.
New Trial To Add To Alzheimer's Puzzle? • Source: Shutterstock

More from Clinical Trials

More from R&D